Imbalance
[용어속성] Term
Imbalance and breakout in the post-epidemic era: Research into the spatial patterns of freight demand network in six provinces of central China
Research Article
[키워드] analyzed
ArcGIS
Characteristics
China
distribution
exhibit
Gephi software
hidden
Imbalance
indicate
information
medium
Perspective
platform
provided
Spread
the epidemic
transfer
Wuhan
[DOI] 10.1371/journal.pone.0250375 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0250375 PMC 바로가기 [Article Type] Research Article
Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19
Immunology
[키워드] Activation
acute respiratory syndrome
antiviral response
caused
coronavirus
coronavirus disease
COVID-19
eliminating
excessive inflammation
explain
Health
host innate immunity
IFN
Imbalance
Immunity
Inflammation
Innate
innate immune system
Innate immunity
mechanisms
potential therapeutic target
public health
response
SARS-CoV-2
Type
Type I IFN
type I interferon
type I interferons
viral infection
virus
viruses
vital role
[DOI] 10.3389/fimmu.2021.633769 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.633769 PMC 바로가기 [Article Type] Immunology
Are all cytokine storms the same?
모든 사이토카인 폭풍은 동일합니까?
Article
[키워드] absence
affected
applied
approach
Biomarker
cause
common
condition
COVID-19
CRS
cytokine
Cytokine release syndrome
Cytokine storm
death
event
foundation
Imbalance
Inflammation
insult
interleukin
Long-term follow-up
other conditions
pathophysiology
Patient
patients
platform
predicted
pro-inflammatory
pro-inflammatory cytokine
pro-inflammatory cytokine release
respond
resulting
SARS-CoV-2
severe disease
syndrome
TGN1412.
tissue damage
Treatment
treatment approach
treatment approaches
undergo
[DOI] 10.1007/s00262-020-02822-2 PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s00262-020-02822-2 PMC 바로가기 [Article Type] Article
Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients
코로나19 환자 중 제2형 당뇨병의 면역학적 특성
Observational Study
[키워드] Admission
analyzed
CD4
CD8
clinical
Concentration
Context
contribute
COVID-19
COVID-19 disease
COVID-19 patient
COVID-19 patients
COVID-19 pneumonia
cytokine
Cytokines
D-dimer
declined
diabetes
Diabetes Mellitus
Diabetic
diabetic patients
dimer
disease
elevated
evaluated
feature
ferritin
flow cytometry
groups
high mortality
Hospitalized
hyperglycemia
Identifier
IL-10
IL-6
IL-8
IL‐6
IL‐8
Imbalance
Immune cell
immune cells
immune system
immunological
immunological characteristics
indicated
laboratory parameter
Laboratory parameters
Lymphocytes
lymphopenia
Mortality
Myoglobin
nitrogen
NK cell
NK cells
non-survivor
Non-survivors
objective
participant
pathogenic mechanism
pathogenic mechanisms
patients
Pneumonia
reduced
reduction
reductions
Registration
remained
Result
Retrospective study
Sample
serum
serum concentrations
severity
significantly
subset
survival
survivor
Survivors
T cell
T cells
T lymphocytes
Th1/Th2 ratio
TNF‐α
Type
type 2 diabete
type 2 diabetes
Type 2 diabetes mellitus
urea
urea nitrogen
were measured
[DOI] 10.3389/fendo.2021.596518 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.3389/fendo.2021.596518 PMC 바로가기 [Article Type] Observational Study
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
COVID-19 환자의 ADAMTS13-von Willebrand 요인 축
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
ADAMTS13
ADAMTS13 Protein
Admission
Antigen
Care
characterized
cofactor
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 progression
cross-sectional
cross-sectional study
Deceased
disease severity
elevated
ENhance
Evidence
evidence of
hypercoagulable
Hypercoagulable state
Imbalance
increased risk
intensity
lung
Lungs
mechanical ventilation
mechanism
median
Microthrombosis
microvasculature
nasal
nasal cannula
Oxygenation
Patient
patients
positive airway pressure
propeptide
ranged
respiratory
risk
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe coronavirus disease
stratified
thromboembolic
Thromboembolic events
thrombosis
von Willebrand factor
vWF
with intensity
[DOI] 10.1111/jth.15191 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/jth.15191 PMC 바로가기 [Article Type] Article
Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection
지속적으로 PCR 양성인 SARS-CoV-2 감염 환자의 면역 반응 및 발병기전
Case Reports
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Beijing
Capital
caused
CD27
CD3
CD38
CD4
CD8
Chain Reaction
China
clinical condition
collected
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19 patients
declined
DPT
function
functions
HLA-DR
Imbalance
immune
Immune cell
immune cells
immune response
Inpatient
key factor
killer cells
Laboratory
nucleic acid
nucleic acid conversion.
occurred
outcome
outcomes
Pathogenesis
Patient
patients
patients with COVID-19
PCR-negative
PCR-positive
PCR-positive patient
Peripheral blood
Peripheral blood sample
peripheral blood samples
phenotype
polymerase chain
polymerase chain reaction
Population
proportion
proportions
respiratory
response
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severity
Spread
T cell
T cells
T killer cell
T killer cells
two group
two groups
university
[DOI] 10.1002/jmv.26287 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1002/jmv.26287 PMC 바로가기 [Article Type] Case Reports
Overcoming limitations in the availability of swabs systems used for SARS-CoV-2 laboratory diagnostics
SARS-CoV-2 실험실 진단에 사용되는 면봉 시스템 가용성의 한계 극복
Article
[키워드] Accuracy
caused
Combination
conducted
COVID-19 patients
Ct values
diagnosis of COVID-19
diagnostic
diagnostics
Effectiveness
Follow-up
generate
Hospitalized
house
Imbalance
Infectious-disease diagnostics
Laboratory
laboratory-confirmed
limitation
pandemic
pandemic spread
positive result
reagent
reagents
recommendation
reflected
respiratory
respiratory specimen
respiratory specimens
RT-PCR
SARS-CoV-2
SARS-CoV-2 RNA
SARS-CoV-2 RT-PCR
significant difference
significant differences
significantly lower
Spread
supply
Swab
swabs
the disease
US CDC
Viral
viral genes
viral infection
[DOI] 10.1038/s41598-021-81782-8 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-81782-8 PMC 바로가기 [Article Type] Article
Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity
경증 또는 중증 증상을 나타내는 SARS CoV-2 감염 환자의 면역 세포 하위 집합의 질병 기간 기반 비교는 중증도에 대한 예후 마커를 식별합니다.
Comparative Study
[키워드] absence
adaptive
adaptive immune cells
Adaptive immunity
addition
Analysis
analyzed
Antibody titer
association
B cells
CD8 T cells
Cell
dendritic cells
determined by
disease
disease severity
event
expression
flow cytometry
follicular
forms
Frequency
functional
healthy subject
help
Humoral immunity
Hyperactivation
identification
identify
IgG
IL‐6
Imbalance
Immune cell
immune cells
Immune profile
India
indicated
infected patient
Infection
innate immune cell
Innate immune cells
Lower
lymphocyte
Lymphocytes
management
material
maturation
mDC
mDCs
memory B cell
memory B cells
Mild
modulation
Monocytes
Multivariate analysis
Neutralizing antibody titer
neutralizing antibody titers
NK cells
observation
Older age
pandemic
Pathogenesis
Patient
patient cohort
patients
positive
presenting
PRNT
PRNT50
Prognostic marker
Prognostic markers
receptor
Result
SARS CoV‐2
SARS‐CoV‐2
SARS‑CoV2
Severe case
severe cases
severe disease
severe symptom
severity
Spectrum
subset
Symptoms
T cell
T cells
T helper cells
therapy
understanding
[DOI] 10.1002/iid3.402 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1002/iid3.402 PMC 바로가기 [Article Type] Comparative Study
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
COVID-19 폐렴 환자에서 호흡 악화 예방을 위한 BIO101의 효능 및 안전성 테스트(COVA 연구): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
20-hydroxyecdysone
absence
accumulation
ACE2
Activation
acute respiratory distress
acute respiratory distress syndrome
adaptive
addition
administration
Airway Pressure
all-cause mortality
ALT
Alter
amenorrhea
Analysis
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
Angiotensin converting enzyme-2
Anti-inflammatory
anticipated
approved
ARDS
arterial oxygen saturation
AST
Asymptomatic
balance
baseline
being
Belgium
beneficiary
Bilirubin
BIO101
Biomarker
Biomarkers
birth control
blinded
Brazil
breath
Cardiomyopathy
Care
Caregivers
caused
clinical development
Clinical finding
Clinical findings
clinical picture
co-morbidities
co-morbidity
collected
Compliance
condition
condom
conducted
confirmation
Consumption
Continuous
Continuous Positive Airway Pressure
Contraception
contraceptive method
coronavirus disease
COVID-19
COVID-19 infection
COVID-19 infection symptom
COVID-19 infection symptoms
COVID-19 patient
COVID-19 patients
criteria
criterion
daily dose
Day
death
defined
Department
Deterioration
develop
diabetes
diagnosis of COVID-19
dialysis
discharge
discharged
disease
dissemination
DMC
dose
double-blind
downstream
ECMO
Effect
effective
Efficacy
Efficacy and safety
EGFR
element
eligible participant
Eligible participants
endotracheal tube
Endpoint
enzyme
etonogestrel
EudraCT
European
evaluate
event
Evidence
evidence of
exclusion criteria
expected
exploratory
extracorporeal membrane oxygenation
female
female participants
Final
FiO2
Flow
following
form
France
French
functional
Gault
Gender
healthcare
healthcare facility
heart disease
High-flow oxygen
higher risk
hospital
hospital care
Hospitalization
Hospitalized
hypersensitivity
hypertension
IBM
ICF
Imbalance
include
Inclusion
independent
indication
Infection
Inflammation
informed consent form
injection
Interim analyses
interim analysis
Intervention
intrauterine device
Intubated
Invasive mechanical ventilation
IWRS system
lactating
limit
Liver function
liver function tests
male participants
marker
Mas receptor
maximum
measure
mechanical ventilation
medical intervention
medication
medications
minute
moderate
morbidities
Moribund
Mortality
mouth
Multiorgan dysfunction
muscles
myocarditis
negative urine pregnancy test
Non-COVID-19
number
obesity
objective
observation
offer
Older
oral contraceptive
outcome
outlined
oxygen
Part
participant
partner
pathway
Pathways
patients with COVID-19
patients with SARS-CoV-2
PCR
performed
Pericarditis
Physical examination
Placebo
placebo-controlled
Pneumonia
positive airway pressure
post-intervention
post-menopausal
powder
pregnancy test
pressure
primary endpoint
proof
proportion
Proportion of participant
protocol
public health
randomised
randomised controlled trial
randomization
RAS
reached
receive
receiving
receptor
recruited
recruitment
Registered
renal
renal disease
renal insufficiency
Renin
renin angiotensin system
renin-angiotensin system
reproduction
required
resource
respiratory
Respiratory distress syndrome
Respiratory failure
Respiratory function
respiratory symptoms
restored
risk
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
SARS-CoV2 spike protein
second
secondary
secondary endpoint
security
severe pneumonia
Shock
Social Security
specimen
Sperm
Spike protein
SpO2
Statistical power
status
Sterilization
Stratification
stratified
study medication
Study protocol
supplementary material
survival
suspicion
Symptom
syndrome
tachypnea
target population
tested
Testing
the primary endpoint
therapeutic
therapeutic option
tissue
Tolerability
Total
total bilirubin
Treatment
treatment arm
treatment period
Triage
Trial
Trial registration
ULN
Urine
USA
variety
vasectomy
Version
Viral load
water
website
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04998-5 PMC 바로가기 [Article Type] Letter